Panel: Reshoring US Pharma: The Realities

Join us as our experts delve into the current state of pharmaceutical manufacturing on American soil, examining the drivers, challenges, and outcomes of the onshoring trend within the US pharma industry

• Examining case studies and success stories that highlight the progress and challenges in realizing onshoring goals within the US pharma market
• Analyzing the impact of regulatory changes and supply chain disruptions on onshoring efforts
• Assessing hybrid Onshoring and Nearshoring